A company insider recently sold 6,272 shares of BioXcel Therapeutics Inc [BTAI]. Should You Sale?
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. BioXcel Therapeutics
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. BioXcel Therapeutics
BioXcel Therapeutics Inc’s recently made public that its Chief Commercial Officer Wiley Matthew T. unloaded Company’s shares for reported $3450.0
BioXcel Therapeutics Inc’s recent filing unveils that its Chief Commercial Officer Wiley Matthew T. unloaded Company’s shares for reported $3450.0
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.